首页> 美国政府科技报告 >Extracellular Hsp90 as a Novel Epigenetic of EMT and Metastatic Risk in Prostate Cancer.

【24h】

Extracellular Hsp90 as a Novel Epigenetic of EMT and Metastatic Risk in Prostate Cancer.

机译：细胞外Hsp90作为前列腺癌EmT和转移风险的新型表观遗传。

获取原文

页面导航

著录项
相似文献
相关主题

著录项

作者
Isaacs, J. S.;
展开▼
作者单位

展开▼
年度 2015
页码 1-28
总页数 28
原文格式 PDF
正文语种 eng
中图分类
关键词
Prostate cancer; Cells(biology); Neoplasms; Proteins; Hsp90; Epithelial to mesenchyal transition; Polycomb; Methyltransferase; Ezh2; Erk signaling;

机译：前列腺癌;细胞（生物学）;肿瘤;蛋白质; Hsp90;上皮至间充质转变; polycomb;甲基转移酶; Ezh2; Erk信号;
入库时间 2022-08-29 10:47:15

相似文献

外文文献
中文文献
专利

1. 前列腺癌印记基因表达的特殊变化一前列腺癌发展和表观遗传调控的预示 [J] . Teodora Ribarska, Klaus-Marius Bastian, Annemarie Koch, 亚洲男性学杂志：英文版 . 2012,第003期
2. Prostate-specific antigen response duration and risk of death for patients with hormone-refractory metastatic prostate cancer. [J] . DAmico AV, Chen MH, Cox MC, Urology . 2005,第3期

机译：激素难治性转移性前列腺癌患者的前列腺特异性抗原反应持续时间和死亡风险。
3. Circulating tumor cell detection in high-risk non-metastatic prostate cancer. [J] . Jasmin Loh, Lidija Jovanovic, Margot Lehman, Journal of Cancer Research and Clinical Oncology . 2014,第12期

机译：高危非转移性前列腺癌中的循环肿瘤细胞检测。
4. Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic, hormone-sensitive prostate cancer. Risk factors and prevention strategies. [J] . Bantis A, Zissimopoulos A, Sountoulides P, Tumori. . 2011,第4期

机译：双膦酸盐诱导的骨转移性激素敏感性前列腺癌患者的颌骨骨坏死。危险因素和预防策略。
5. Self assembled monolayers versus iron oxide nanoparticles modified surfaces: Two functionalization strategies for femtomolar detection of prostate specific antigen: Comparative study between two electrochemical biosensors for femtomolar detection of prostate specific antigen [C] . Nesrine Blel, Nourdin Yaakoubi, Asma Omezzine, IEEE Sensors . 2016

机译：自组装单分子层与氧化铁纳米粒子修饰的表面：飞沫检测前列腺特异抗原的两种功能化策略：两种飞沫检测前列腺特异抗原的电化学生物传感器之间的比较研究
6. Development of Novel Nanomedicines for Treatment of Primary and Metastatic Prostate Cancer. [D] . Aydin, Omer. 2016

机译：开发用于治疗原发性和转移性前列腺癌的新型纳米药物。
7. A phase II trial of ganetespib a heat shock protein 90 Hsp90) inhibitor in patients with docetaxel-pretreated metastatic castrate-resistant prostate cancer (CRPC)-a prostate cancer clinical trials consortium (PCCTC) study [O] . Manish K. Thakur, Lance K. Heilbrun, Shijie Sheng, -1

机译：ganetespib（一种热休克蛋白90 Hsp90）抑制剂的II期临床试验在多西他赛预处理的转移性去势抵抗性前列腺癌（CRPC）患者中进行-前列腺癌临床试验联盟（PCCTC）研究
8. The importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer. [O] . Noel Clarke, Adnan Ali, Hitesh Mistry, 2018

机译：非区域淋巴结在原发性转移前列腺癌中指派风险的重要性。
9. Extracellular Hsp90 as a Novel Epigenetic of EMT and Metastatic Risk in Prostate Cancer. [R] . Isaacs, J. S. 2014

机译：细胞外Hsp90作为前列腺癌EmT和转移风险的新型表观遗传。

Extracellular Hsp90 as a Novel Epigenetic of EMT and Metastatic Risk in Prostate Cancer.

著录项

相似文献

相关主题

期刊订阅